[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PT3106875T - Método para a deteção de cancro - Google Patents

Método para a deteção de cancro

Info

Publication number
PT3106875T
PT3106875T PT161814330T PT16181433T PT3106875T PT 3106875 T PT3106875 T PT 3106875T PT 161814330 T PT161814330 T PT 161814330T PT 16181433 T PT16181433 T PT 16181433T PT 3106875 T PT3106875 T PT 3106875T
Authority
PT
Portugal
Prior art keywords
cancer
detection
Prior art date
Application number
PT161814330T
Other languages
English (en)
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of PT3106875T publication Critical patent/PT3106875T/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1037Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4727Calcium binding proteins, e.g. calmodulin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/723Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT161814330T 2007-10-25 2008-10-23 Método para a deteção de cancro PT3106875T (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2007277747 2007-10-25
JP2007277697 2007-10-25
JP2007279512 2007-10-26
JP2007279580 2007-10-26
JP2008254170 2008-09-30

Publications (1)

Publication Number Publication Date
PT3106875T true PT3106875T (pt) 2020-06-22

Family

ID=40579577

Family Applications (4)

Application Number Title Priority Date Filing Date
PT161814165T PT3106873T (pt) 2007-10-25 2008-10-23 Método para a deteção de cancro
PT161814298T PT3106874T (pt) 2007-10-25 2008-10-23 Método para a deteção de cancro
PT161814330T PT3106875T (pt) 2007-10-25 2008-10-23 Método para a deteção de cancro
PT88423918T PT2207037T (pt) 2007-10-25 2008-10-23 Método para a deteção de cancro

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PT161814165T PT3106873T (pt) 2007-10-25 2008-10-23 Método para a deteção de cancro
PT161814298T PT3106874T (pt) 2007-10-25 2008-10-23 Método para a deteção de cancro

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT88423918T PT2207037T (pt) 2007-10-25 2008-10-23 Método para a deteção de cancro

Country Status (11)

Country Link
US (1) US9249409B2 (pt)
EP (4) EP2207037B1 (pt)
JP (4) JP5439815B2 (pt)
KR (4) KR101715666B1 (pt)
CN (5) CN106086177B (pt)
AU (1) AU2008314929B2 (pt)
CA (4) CA2703356C (pt)
DK (4) DK3106875T3 (pt)
ES (4) ES2798266T3 (pt)
PT (4) PT3106873T (pt)
WO (1) WO2009054475A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009278387B2 (en) 2008-08-05 2015-07-09 Toray Industries, Inc. Cancer detection method
JP5691172B2 (ja) 2008-08-05 2015-04-01 東レ株式会社 癌の治療及び予防用医薬組成物
MX340015B (es) 2010-02-04 2016-06-22 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
RU2445625C1 (ru) * 2011-01-11 2012-03-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Способ прогнозирования риска развития многоузловых поражений при лейомиоме матки
PT2741085T (pt) 2011-08-04 2017-06-30 Toray Industries Método para a deteção de cancro prancreático
DK2740796T3 (en) 2011-08-04 2017-07-24 Toray Industries Pharmaceutical composition for the treatment and / or prevention of cancer
CN103717238B (zh) 2011-08-04 2016-10-12 东丽株式会社 胰癌的治疗和/或预防用药物组合物
BR112014021102A2 (pt) 2012-02-21 2021-12-28 Toray Industries Anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo
BR112014021101A2 (pt) 2012-02-21 2022-03-22 Toray Industries Anticorpo, composição farmacêutica, droga de combinação, dna e método de tratamento e/ou prevenção de câncer, uso de um anticorpo
RU2640245C2 (ru) 2012-03-30 2017-12-27 Торэй Индастриз, Инк. Фармацевтическая композиция для лечения и/или предотвращения рака печени
PT2832366T (pt) 2012-03-30 2018-01-25 Toray Industries Composição farmacêutica para o tratamento e/ou a prevenção de cancro de vesícula biliar
CN104471403B (zh) * 2012-07-19 2017-03-01 东丽株式会社 癌的检测方法
PT2876447T (pt) 2012-07-19 2020-02-03 Toray Industries Método para deteção de cancro
KR102255616B1 (ko) 2013-08-09 2021-05-25 도레이 카부시키가이샤 암의 치료 및/또는 예방용 의약 조성물
JP5995117B2 (ja) * 2015-01-26 2016-09-21 国立大学法人 筑波大学 可溶型cd155タンパク質を用いた癌の検出方法
US11959928B2 (en) * 2017-12-20 2024-04-16 Trears Ltd. Method for measuring average cortisol and glucose concentrations in earwax

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355623B2 (en) * 1998-09-24 2002-03-12 Hopital-Sainte-Justine Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage
JP2005506033A (ja) * 2000-10-13 2005-03-03 イーオーエス バイオテクノロジー インコーポレイテッド 前立腺癌の診断法、前立腺癌モジュレータースクリーニングの組成物及び方法
US20040029114A1 (en) * 2001-01-24 2004-02-12 Eos Technology, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
CA2447212A1 (en) * 2001-03-29 2002-10-24 Incyte Genomics, Inc. Secretory molecules
US20030108963A1 (en) * 2001-07-25 2003-06-12 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer
US20030124579A1 (en) * 2001-09-05 2003-07-03 Eos Biotechnology, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
US20070237770A1 (en) * 2001-11-30 2007-10-11 Albert Lai Novel compositions and methods in cancer
AU2003272423A1 (en) * 2002-09-13 2004-04-30 University Of Massachusetts Centrosome proteins and uses thereof
JP2006517094A (ja) * 2002-10-22 2006-07-20 ヌベロ, インコーポレイテッド 新規核酸およびポリペプチド
CN1852974A (zh) * 2003-06-09 2006-10-25 密歇根大学董事会 用于治疗和诊断癌症的组合物和方法
US10179935B2 (en) * 2003-07-17 2019-01-15 Pacific Edge Limited Markers for detection of gastric cancer
US7807392B1 (en) * 2003-09-15 2010-10-05 Celera Corporation Lung disease targets and uses thereof
EP1522594A3 (en) * 2003-10-06 2005-06-22 Bayer HealthCare AG Methods and kits for investigating cancer
CN1657537A (zh) * 2004-02-19 2005-08-24 中国人民解放军军事医学科学院放射医学研究所 一种中心体定位的新基因及其在医药领域中的应用
JP2007522791A (ja) * 2004-02-24 2007-08-16 オンコセラピー・サイエンス株式会社 結腸直腸癌を診断する方法
US7560233B2 (en) * 2004-06-16 2009-07-14 University Of Massachusetts Oxidative DNA damage protection
US20070099209A1 (en) * 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
ES2824684T3 (es) * 2007-10-25 2021-05-13 Toray Industries Inductor de la respuesta inmunitaria

Also Published As

Publication number Publication date
EP2207037A1 (en) 2010-07-14
DK3106875T3 (da) 2020-06-02
DK3106873T3 (da) 2019-09-23
EP3106874A1 (en) 2016-12-21
JP5713035B2 (ja) 2015-05-07
JP2013101147A (ja) 2013-05-23
EP3106875A1 (en) 2016-12-21
JP2013101148A (ja) 2013-05-23
CA3076730C (en) 2022-06-21
DK2207037T3 (en) 2016-12-19
JP5713037B2 (ja) 2015-05-07
CN106053833B (zh) 2018-12-25
CA3076717A1 (en) 2009-04-30
EP3106874B1 (en) 2020-04-01
CN106086177B (zh) 2021-09-10
JPWO2009054475A1 (ja) 2011-03-10
KR101633351B1 (ko) 2016-06-27
KR101715666B1 (ko) 2017-03-13
CN106093398A (zh) 2016-11-09
ES2788152T3 (es) 2020-10-20
CA3076730A1 (en) 2009-04-30
KR20100083768A (ko) 2010-07-22
PT3106874T (pt) 2020-05-08
KR20150041807A (ko) 2015-04-17
EP3106873A1 (en) 2016-12-21
KR101715661B1 (ko) 2017-03-13
KR20150041809A (ko) 2015-04-17
US20100297646A1 (en) 2010-11-25
EP3106873B1 (en) 2019-07-17
AU2008314929A1 (en) 2009-04-30
ES2605646T3 (es) 2017-03-15
CN106086177A (zh) 2016-11-09
JP5713036B2 (ja) 2015-05-07
KR20150041808A (ko) 2015-04-17
EP2207037A4 (en) 2011-03-16
CN101836116A (zh) 2010-09-15
JP5439815B2 (ja) 2014-03-12
ES2798266T3 (es) 2020-12-10
US9249409B2 (en) 2016-02-02
CA2703356A1 (en) 2009-04-30
ES2748390T3 (es) 2020-03-16
WO2009054475A1 (ja) 2009-04-30
CN106053833A (zh) 2016-10-26
PT3106873T (pt) 2019-10-18
CA3076845C (en) 2022-06-07
JP2013101149A (ja) 2013-05-23
AU2008314929B2 (en) 2014-07-10
CN106093399A (zh) 2016-11-09
EP3106875B1 (en) 2020-04-29
CN106093399B (zh) 2019-01-25
CA3076845A1 (en) 2009-04-30
CA2703356C (en) 2020-05-05
CA3076717C (en) 2023-01-03
PT2207037T (pt) 2016-12-09
CN106093398B (zh) 2019-01-29
EP2207037B1 (en) 2016-09-07
DK3106874T3 (da) 2020-06-02

Similar Documents

Publication Publication Date Title
EP2207037A4 (en) METHOD OF DETECTING CANCER
EP2325648A4 (en) METHOD OF DETECTING CANCER
EP2187217A4 (en) METHOD FOR DETECTING GYNECOLOGIC CANCER
EP2423323A4 (en) METHOD OF TUMOR ASSESSMENT
PL3050974T3 (pl) Sposób detekcji narażonych na wilgoć pasków testowych do moczu
EP2438197A4 (en) METHOD OF CANCER DETECTION
EP2428584A4 (en) COLORECTAL TUMOR DETECTION METHOD
EP2147309A4 (en) METHODS OF DETECTING PRECLAMPSY
HK1142128A1 (en) Methods of prognosis
EP2498094A4 (en) METHOD OF DETECTING PANCREATIC CANCER
IL196208A0 (en) Methods for cancer treatment using tak1 inhibitors
GB0820309D0 (en) Detection of cancer
EP2354790A4 (en) METHOD FOR DETERMINING CANCER OF PROSTATE
EP2147298A4 (en) PROOF OF CANCER MARKERS
EP2433137A4 (en) PROCEDURE FOR KIDNEY CANCER DETECTION
EP2035439A4 (en) RISK ASSESSMENT FOR COLORECTAL CANCER
EP2272538A4 (en) METHOD FOR DETECTION OF CANCER OF BLADDER
EP2467140A4 (en) METHOD FOR CANCER TREATMENT
GB0701599D0 (en) Method of detection
ZA201007010B (en) Rapid detection of mycobateria
EP2337868A4 (en) DETECTION OF TUMORS OF GRANULOSA
PT2356252E (pt) Método para a deteção urinária do cancro da bexiga
GB0722734D0 (en) Detection method
EP2194372A4 (en) FLUORESCENCE DETECTION METHOD
GB0613182D0 (en) Method of detection